Melhores HIFU para o tratamento do cancro da próstata médicos - TOP-15 médicos

O Dr. Solak é especialista no tratamento de vários tipos de cancro, incluindo o cancro da próstata, com formação no Instituto do Cancro da Universidade de Hacettepe.

• Concluiu a especialização no Instituto do Cancro da Universidade de Hacettepe
• Trabalhou no MD Anderson Cancer Center da Universidade do Texas
• Experiência no tratamento de cancros da mama, testículo, ovário, pulmão e gastrointestinais

O Prof. Merimsky lidera a Unidade de Oncologia Ortopédica no Sourasky Medical Center, especializando-se em tratamentos avançados para câncer de próstata, como o HIFU.

• Mais de 25 anos de experiência em oncologia
• Bolsa de especialização (Fellowship) em sarcoma de tecidos moles e ósseo no Institut Gustave Roussy, Paris
• Membro do corpo docente do grupo Sarcoma da ESMO
• Vastas publicações sobre resultados em oncologia

O Prof. Jack Baniel lidera a pesquisa em uro-oncologia e realiza cirurgias avançadas de câncer de próstata no Rabin Medical Center. Ele é especializado em técnicas de preservação nervosa para melhores resultados clínicos para os pacientes.

• Professor e Chefe de Urologia com vasta experiência clínica
• Publicou mais de 100 artigos científicos sobre uro-oncologia
• Membro de associações urológicas europeias e americanas
• Participa em estudos de pesquisa clínica globais
• Fundador do Departamento Oncourológico no Hospital Beilinson

O Dr. Alemdar é especializado em oncologia médica, com foco no tratamento do câncer de próstata, no Complexo Hospitalar Medical Park Antalya.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência em medicina interna e oncologia
• Treinado na Universidade Akdeniz – uma instituição médica líder na Turquia

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
Autologous bone marrow mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male infertility, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Stem Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​

O Dr. Sridhar P.S. é especialista em HIFU para o tratamento do cancro da próstata no HCG Manavata Cancer Centre, com vasta formação em radioterapia e oncologia.

• Membro da Indian Association of Hyperthermia Oncology
• Formado em instituições de prestígio, incluindo a Banaras Hindu University
• Membro do Bangalore Oncology Group

O Dr. Chaitainya Borde realizou mais de 30.000 exames de PET e atendeu 1.000 pacientes com cancro da tiroide, trazendo uma vasta experiência no tratamento do cancro da próstata no HCG Manavata Cancer Centre.

• 12 anos de experiência em medicina nuclear
• Especialista em terapias com iodo radioativo e Lu-177 RN
• Artigos publicados em revistas médicas
• Proficiente em exames de PET-CT e cardiologia nuclear

A Dra. Shruti Kate formou-se no Tata Memorial Hospital – o principal centro de oncologia da Índia – especializando-se em oncologia médica com foco em cancros geniturinários.

• Especialização em cancros do pulmão, mama e geniturinários
• Interesse especial em imunoterapia para cancros avançados
• Apresentou investigação na Conferência Mundial sobre Cancro do Pulmão
• Membro da ASCO, ESMO e outras sociedades oncológicas líderes

O Dr. Lalit Banswal realizou mais de 10.000 cirurgias de grande porte com foco em procedimentos oncológicos minimamente invasivos no HCG Manavata Cancer Centre.

• Especializado em cirurgia de câncer gastrointestinal
• Treinado no Tata Medical Centre, Kolkata
• Publicou vários artigos de pesquisa nacionais e internacionais
• Conhecido pela abordagem ética e amigável ao paciente

Mais de 19 anos de experiência em oncologia cirúrgica com mais de 50.000 cirurgias de câncer realizadas – O Dr. Nagarkar concentra-se na melhoria da qualidade de vida dos pacientes.

• Formado no Tata Memorial Hospital e no Royal College of Surgeons, Edimburgo
• Especialista em Oncologia Cirúrgica de Mama e Torácica
• Envolvido em mais de 200 ensaios clínicos
• Professor de Subespecialidade DNB em Oncologia Cirúrgica